MDxHealth SA (MDXH)
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Last price
- $0.66
- As of
Kresmion compiles this page from MDXH's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MDxHealth SA (MDXH): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-03.
See the full MDXH dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MDXH on one page. Preview it with sample data, then open it live with a free account.
Preview the MDXH dossierActive signals for MDXH
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 9.0%, EPS $-0.18 vs $-0.1979 estimate
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +745% to MDXH (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 58% of MDXH (2026Q2)
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 68% of MDXH (2026Q1)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +366% to MDXH (2026Q1)
FREE, NO ACCOUNT
Every signal on MDXH, as it fires
You are seeing 5 of 11 signals recorded on MDXH since 2026-06-05.
The five above landed across 3 days. The other 6 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MDXH (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP B5950S113 · 2026Q2 | $209K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP B5950S113 · 2026Q2 | $133K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP B5950S113 · 2026Q2 | $94K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MDXH
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
MDXH mentioned in Kresmion daily briefs
MDXH against its peers
MDXH's operating margin of -13.4% ranks in the 68th percentile of 16 Diagnostics & Research sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | MDXH | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 108M USD | 38.7M USD | 75 | 17 |
| Gross margin | 64.5% | 62.3% | 63 | 11 |
| Operating margin | -13.4% | -33.1% | 68 | 16 |
| Net margin | -31.1% | -31.8% | 53 | 17 |
| Return on equity | n/a | -10.3% | n/a | 15 |
| 1 year | n/a | -27.6% | n/a | 14 |
Peers (21): MBAI, PRPO, IDXG, IMDX, QUCY, FONR, BNR, LDDD, BDSX, AWHL, ADVB, NDRA, XWEL, ISPC, OPK, PSNL, NEO, CDNA, FUNI, BLLN, NSTM. Left out: ANPCF (no annual filing), PMDI (period gap), BIAF (no annual filing), NOTV (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MDXH: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow MDXH on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to MDXH for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.